Speciality Medicines Ltd Appoints Investor Relations Agency

Speciality Medicines Ltd has appointed Capital Bridge Advisory Service Private Limited, operating under the brand Capital Bridge Advisors, as its Investor and Public Relations Agency. This strategic move aims to enhance the company's investor relations and capital market communication efforts. The agency will focus on fostering engagement with the investment community, promoting transparency, and ensuring effective communication with stakeholders. This appointment underscores the company's commitment to strengthening its investor relations framework in line with evolving market expectations.